Eight-week bedaquiline-linezolid noninferior for TB

A strategy of eight weeks of bedaquiline-linezolid is noninferior to a standard regimen for tuberculosis, according to a study published online Feb. 20 in the New England Journal of Medicine to coincide with the annual Conference on Retroviruses and Opportunistic Infections, held from Feb. 19 to 22 in Seattle.

Leave A Comment

Your email address will not be published. Required fields are marked *